ArticleRenal failure2024
Acute kidney disease in hospitalized pediatric patients: risk prediction based on an artificial intelligence approach.
Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The application of machine learning in predicting post-cardiac surgery acute kidney injury in pediatric patients: a systematic review.Frontiers in pediatrics · 2025Pooled it
- Early, frequent, yet reversible: acute kidney injury after hematopoietic stem cell transplantation in pediatric Fanconi anemia and long-term renal outcomes.Pediatric nephrology (Berlin, Germany) · 2026Article
- Acute kidney diseases and disorders in children with bloodstream infection: frequency, predictors, and outcomes.Pediatric nephrology (Berlin, Germany) · 2026Article
- Research progress on biomarkers for acute kidney injury in children.Pediatric nephrology (Berlin, Germany) · 2026Review
- AI-powered insights in pediatric nephrology: current applications and future opportunities.Pediatric nephrology (Berlin, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute kidney injury (AKI) and acute kidney disease (AKD) are prevalent among pediatric patients, both linked to increased mortality and extended hospital stays. Early detection of kidney injury is crucial for improving outcomes. This study presents a machine learning-based risk prediction model for AKI and AKD in pediatric patients, enabling personalized risk predictions.
methodsData from 2,346 hospitalized pediatric patients, collected between January 2020 and January 2023, were divided into an 85% training set and a 15% test set. Predictive models were constructed using eight machine learning algorithms and two ensemble algorithms, with the optimal model identified through AUROC. SHAP was used to interpret the model, and an online prediction tool was developed with Streamlit to predict AKI and AKD.
resultsThe incidence of AKI and AKD were 14.90% and 16.26%, respectively. Patients with AKD combined with AKI had the highest mortality rate, at 6.94%, when analyzed by renal function trajectories. The LightGBM algorithm showed superior predictive performance for both AKI and AKD (AUROC: 0.813, 0.744). SHAP identified top predictors for AKI as serum creatinine, white blood cell count, neutrophil count, and lactate dehydrogenase, while key predictors for AKD included proton pump inhibitor, blood glucose, hemoglobin, and AKI grade.
conclusionThe high incidence of AKI and AKD among hospitalized children warrants attention. Renal function trajectories are strongly associated with prognosis. Supported by a web-based tool, machine learning models can effectively predict AKI and AKD, facilitating early identification of high-risk pediatric patients and potentially improving outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.